KOSELUGO
Active substance: selumetinib
CAPSULE · SELUMETINIB 25 mg/1
United StatesActive
Marketing holder: AstraZeneca Pharmaceuticals LP
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- SELUMETINIB · 25 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12090-7816-7a21-b07c-09b75477ec00,01a1209b-8aa7-736f-9742-963ede98a03f,01a1209d-d791-7f32-a262-1e290369aa5a,01a1209d-d797-7184-a836-7e1785046ec1;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0310-0625
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0310-0625 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0310-0625 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0310-0625 · Verified 2026-10-09 · open in source